d. Phase 3 prospective, uncontrolled, multicenter study evaluting pharmacokinetics, efficacy, safety, and immunogenicity of BAX855 (PEGylated full-length Recombinant FVIII )in previously treated pediatric patients with severe hemophilia A | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

d. Phase 3 prospective, uncontrolled, multicenter study evaluting pharmacokinetics, efficacy, safety, and immunogenicity of BAX855 (PEGylated full-length Recombinant FVIII )in previously treated pediatric patients with severe hemophilia A

KOÇ ŞENOL S. B.

Diğer Uluslararası Fon Programları, 2014 - 2015

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Ağustos 2014
Bitiş Tarihi: Ocak 2015